Showing results (191-200 of 315) with videos related to
Sort By:
Pageof 32
Cancer Chemotherapy and Pharmacology|January 1, 1994
GM-CSF, carboplatin, doxorubicin: a phase I studyE A Poplin, D S Alberts, J J Rinehart, et al.Nutrition and Cancer|January 1, 1996
Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green teaH L Gensler, B N Timmermann, S Valcic, et al.Journal of the National Cancer Institute|August 1, 1980
Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor modelD S Alberts, Y M Peng, H S Chen, et al.Seminars in Oncology|April 1, 1992
A phase I trial of fluorouracil, leucovorin, and recombinant interferon alpha-2b in patients with advanced malignancyC W Taylor, M R Modiano, M E Woodson, et al.Journal of Medicinal Chemistry|February 13, 1999
Novel antitumor 2-cyanoaziridine-1-carboxamidesB S Iyengar, R T Dorr, D S Alberts, et al.Anti-Cancer Drugs|June 1, 1991
A phase I trial of 14-day continuous intravenous infusion mitoxantroneW H Kreisle, D S Alberts, A F List, et al.Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignanciesA M Lopez, M Ketchum, H Nichols, et al.American Journal of Clinical Oncology|April 1, 1988
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group StudyD D Von Hoff, R Kronmal, R V O'Toole, et al.Journal of Pain and Symptom Management|April 1, 1990
Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimenP M Plezia, D S Alberts, J F Kessler, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patientsJ F Kessler, D S Alberts, P M Plezia, et al.Pageof 32